As of May 7, 2008

• 30-day notice of information collection under review: Records and Reports of Registrants. (May 7, 2008)

• 30-Day Notice of Information Collection Under Review; U.S. Official Order Forms for Schedule I and II Controlled Substances (Accountable Forms), Order Form Requisition--DEA Form 222 and 222a (May 7, 2008)

As of May 5, 2008

• Lin Zhi International Inc (May 2, 2008)

• Abbott Laboratories, DBA Knoll Pharmaceutical Company (May 2, 2008)

• Sigma Aldrich Manufacturing LLC (May 2, 2008)

As of May 1, 2008

• Change in DEA Registration Requirements to Handle Iodine (PDF) (April 2008)

As of April 25, 2008

• Proposed Rule - Classification of Three Steroids as Schedule III Anabolic Steroids Under the Controlled Substances Act (April 25, 2008)

As of April 18, 2008

• 30-Day Notice of Information Collection Under Review; ARCOS Transaction Reporting; DEA Form 333. (April 17, 2008)

• 30-Day Notice of Information Collection Under Review; Report of Theft or Loss of Controlled Substances; DEA Form 106. (April 17, 2008)

As of April 16, 2008

• Research Triangle Institute (April 16, 2008)

• JFC Technologies, LLC (April 16, 2008)

• Aldrich Chemical Company Inc., DBA Isotec (April 16, 2008)

• Research Triangle Institute (April 16, 2008)

As of April 11, 2008

• Organix Inc. (April 11, 2008)

As of April 9, 2008

• Proposed Rule - Control of Immediate Precursor Used in the Illicit Manufacture of Fentanyl as a Schedule II Controlled Substance (April 9, 2008)